Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Alpha-actinin-1 (ACTN1) is a non-muscle cytoskeletal protein belonging to the spectrin superfamily, primarily functioning as a **F-actin cross-linking protein** that anchors actin filaments to various intracellular structures[1][2][3][4]. Expressed in non-muscle cells, ACTN1 is localized along microfilament bundles and adherens-type junctions, where it tethers actin to the plasma membrane and stabilizes cell–cell adhesion. It plays central roles in **cytoskeletal organization, cell adhesion, migration, and signal transduction**. In immune cells such as T lymphocytes, it mediates cytoskeletal interactions for immune synapse formation. Disease associations include bleeding disorders (notably macrothrombocytopenia)[3], and tumor-specific splicing of ACTN1 has been observed in certain cancers, suggesting biomarker utility[1]. No drugs directly target ACTN1, but its interactome includes receptors, actin-binding partners, and signaling molecules[2][3][4].
Not applicable (no specific drugs targeting ACTN1 directly)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Alpha-actinin-1 (ACTN1).